Literature DB >> 17433130

Retrospective survey of Chikungunya disease in Réunion Island hospital staff.

F Staikowsky1, K Le Roux, I Schuffenecker, P Laurent, P Grivard, A Develay, A Michault.   

Abstract

Réunion Island (Indian Ocean) has been suffering from its first known Chikungunya virus (CHIKV) epidemic since February 2005. To achieve a better understanding of the disease, a questionnaire was drawn up for hospital staff members and their household. CHIKV infected about one-third of the studied population, the proportion increasing with age and being higher in women. Presence of a garden was associated with CHIKV infection. The geographical distribution of cases was concordant with insect vector Aedes albopictus distribution. The main clinical signs were arthralgia and fever. The disease evolved towards full recovery in 34.4% of cases, a relapse in 55.6%, or a chronic form in 10%. Paracetamol was used as a painkiller in 95% of cases, sometimes associated with non-steroidal anti-inflammatory drugs, corticoids, or traditional herbal medicine. The survey provided valuable information on the factors that favour transmission, the clinical signs, the importance of relapses and the therapies used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433130      PMCID: PMC2870803          DOI: 10.1017/S0950268807008424

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand.

Authors:  W M HAMMON; A RUDNICK; G E SATHER
Journal:  Science       Date:  1960-04-15       Impact factor: 47.728

2.  [Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo].

Authors:  J J Muyembe-Tamfum; C N Peyrefitte; R Yogolelo; E Mathina Basisya; D Koyange; E Pukuta; M Mashako; H Tolou; J P Durand
Journal:  Med Trop (Mars)       Date:  2003

3.  Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006.

Authors:  C Paquet; I Quatresous; J-L Solet; D Sissoko; P Renault; V Pierre; H Cordel; C Lassalle; J Thiria; H Zeller; I Schuffnecker
Journal:  Euro Surveill       Date:  2006-02-02

4.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Authors:  R Edelman; C O Tacket; S S Wasserman; S A Bodison; J G Perry; J A Mangiafico
Journal:  Am J Trop Med Hyg       Date:  2000-06       Impact factor: 2.345

Review 5.  Ross River virus: molecular and cellular aspects of disease pathogenesis.

Authors:  Nestor E Rulli; Andreas Suhrbier; Linda Hueston; Mark T Heise; Daniela Tupanceska; Ali Zaid; Anja Wilmes; Kerry Gilmore; Brett A Lidbury; Surendran Mahalingam
Journal:  Pharmacol Ther       Date:  2005-09       Impact factor: 12.310

6.  [Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women].

Authors:  Pierre-Yves Robillard; Brahim Boumahni; Patrick Gérardin; Alain Michault; Alain Fourmaintraux; Isabelle Schuffenecker; Magali Carbonnier; Sam Djémili; Ghassan Choker; Madeleine Roge-Wolter; Georges Barau
Journal:  Presse Med       Date:  2006-05       Impact factor: 1.228

7.  Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection.

Authors:  M Soden; H Vasudevan; B Roberts; R Coelen; G Hamlin; S Vasudevan; J La Brooy
Journal:  Arthritis Rheum       Date:  2000-02

8.  In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.

Authors:  S Briolant; D Garin; N Scaramozzino; A Jouan; J M Crance
Journal:  Antiviral Res       Date:  2004-02       Impact factor: 5.970

9.  Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak.

Authors:  Isabelle Schuffenecker; Isabelle Iteman; Alain Michault; Séverine Murri; Lionel Frangeul; Marie-Christine Vaney; Rachel Lavenir; Nathalie Pardigon; Jean-Marc Reynes; François Pettinelli; Leon Biscornet; Laure Diancourt; Stéphanie Michel; Stéphane Duquerroy; Ghislaine Guigon; Marie-Pascale Frenkiel; Anne-Claire Bréhin; Nadège Cubito; Philippe Desprès; Frank Kunst; Félix A Rey; Hervé Zeller; Sylvain Brisse
Journal:  PLoS Med       Date:  2006-05-23       Impact factor: 11.069

10.  New insights into the antiviral effects of chloroquine.

Authors:  Andrea Savarino; Livia Di Trani; Isabella Donatelli; Roberto Cauda; Antonio Cassone
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

View more
  28 in total

1.  Chikungunya Virus Disease among Travelers-United States, 2014-2016.

Authors:  Nicole P Lindsey; J Erin Staples; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.

Authors:  Brieg Couzigou; Anne Criquet-Hayot; Emilie Javelle; Sandrine Tignac; Edith Mota; François Rigaud; Alizé Alain; Odile Troisgros; Sandrine Pierre-Francois; Sylvie Abel; Rishika Banydeen; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

4.  Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.

Authors:  Karen M Gallegos; George L Drusano; David Z D Argenio; Ashley N Brown
Journal:  J Infect Dis       Date:  2016-08-05       Impact factor: 5.226

5.  Association of ABO blood groups with Chikungunya virus.

Authors:  Naresh C V M Kumar; Mahathi Nadimpalli; Vishnu R Vardhan; Sai D V R Gopal
Journal:  Virol J       Date:  2010-06-25       Impact factor: 4.099

6.  The Chikungunya epidemic in Italy and its repercussion on the blood system.

Authors:  Giancarlo Maria Liumbruno; Deanna Calteri; Kyriakoula Petropulacos; Andrea Mattivi; Claudio Po; Pierluigi Macini; Ivana Tomasini; Paolo Zucchelli; Anna Rita Silvestri; Vittorio Sambri; Simonetta Pupella; Liviana Catalano; Vanessa Piccinini; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

7.  Chikungunya virus replication in skeletal muscle cells is required for disease development.

Authors:  Anthony J Lentscher; Mary K McCarthy; Nicholas A May; Bennett J Davenport; Stephanie A Montgomery; Krishnan Raghunathan; Nicole McAllister; Laurie A Silva; Thomas E Morrison; Terence S Dermody
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

8.  Reemergence of Chikungunya virus in Indian Subcontinent.

Authors:  C V M Naresh Kumar; D V R Sai Gopal
Journal:  Indian J Virol       Date:  2010-09-03

9.  Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study.

Authors:  Man-Koumba Soumahoro; Patrick Gérardin; Pierre-Yves Boëlle; Joelle Perrau; Adrian Fianu; Jacques Pouchot; Denis Malvy; Antoine Flahault; François Favier; Thomas Hanslik
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

10.  Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.

Authors:  Frederik Staikowsky; François Talarmin; Philippe Grivard; Abdel Souab; Isabelle Schuffenecker; Karin Le Roux; Marc Lecuit; Alain Michault
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.